Universe · entity
Parkman Healthcare Partners LLC
Institutional manager (13F) · CIK 1777015
13F holdings · as of 2026-03-31 · top 50 · reported portfolio $841M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | STRYKER CORPORATION | $51M | 154,771 |
| 2 | DEXCOM INC | $43M | 689,822 |
| 3 | KALVISTA PHARMACEUTICALS INC | $37M | 1,835,506 |
| 4 | INSULET CORP | $33M | 156,561 |
| 5 | ELI LILLY & CO | $32M | 34,616 |
| 6 | PTC THERAPEUTICS INC | $29M | 431,364 |
| 7 | XENON PHARMACEUTICALS INC | $29M | 497,035 |
| 8 | BOSTON SCIENTIFIC CORP | $28M | 448,768 |
| 9 | CVS HEALTH CORP | $28M | 387,306 |
| 10 | ARCUS BIOSCIENCES INC | $26M | 1,207,274 |
| 11 | LIVANOVA PLC | $26M | 403,965 |
| 12 | ZIMMER BIOMET HOLDINGS INC | $24M | 269,557 |
| 13 | MBX BIOSCIENCES INC | $24M | 800,037 |
| 14 | ANI PHARMACEUTICALS INC | $22M | 280,575 |
| 15 | SYNDAX PHARMACEUTICALS INC | $21M | 901,511 |
| 16 | QIAGEN NV | $20M | 500,000 |
| 17 | ENVISTA HOLDINGS CORPORATION | $18M | 711,693 |
| 18 | EYEPOINT INC | $17M | 1,354,800 |
| 19 | ABBVIE INC | $16M | 75,000 |
| 20 | BIOCRYST PHARMACEUTICALS INC | $16M | 1,708,099 |
| 21 | IQVIA HLDGS INC | $15M | 86,702 |
| 22 | AGIOS PHARMACEUTICALS INC | $14M | 403,525 |
| 23 | ILLUMINA INC | $14M | 110,370 |
| 24 | EDWARDS LIFESCIENCES CORP | $13M | 167,155 |
| 25 | NEUROCRINE BIOSCIENCES INC | $13M | 99,069 |
| 26 | KINIKSA PHARMACEUTICALS INTL | $12M | 259,184 |
| 27 | ASSEMBLY BIOSCIENCES INC | $11M | 411,227 |
| 28 | STRUCTURE THERAPEUTICS INC | $11M | 232,093 |
| 29 | MCKESSON CORP | $11M | 12,676 |
| 30 | STOKE THERAPEUTICS INC | $11M | 336,519 |
| 31 | VIRIDIAN THERAPEUTICS INC | $11M | 557,936 |
| 32 | WAYSTAR HLDG CORP | $11M | 443,058 |
| 33 | MINERALYS THERAPEUTICS INC | $10M | 380,137 |
| 34 | EDGEWISE THERAPEUTICS INC | $10M | 322,828 |
| 35 | XERIS BIOPHARMA HOLDINGS INC | $10M | 1,721,264 |
| 36 | TENET HEALTHCARE CORP | $9M | 50,123 |
| 37 | ARTIVION INC | $9M | 252,014 |
| 38 | NUVALENT INC | $9M | 88,078 |
| 39 | ALPHATEC HLDGS INC | $9M | 823,763 |
| 40 | ALNYLAM PHARMACEUTICALS INC | $9M | 26,916 |
| 41 | AXOGEN INC | $9M | 268,160 |
| 42 | IMMUNOME INC | $9M | 403,487 |
| 43 | AMYLYX PHARMACEUTICALS INC | $9M | 621,458 |
| 44 | IDEXX LABS INC | $8M | 15,000 |
| 45 | WATERS CORP | $8M | 26,447 |
| 46 | ADAPTIVE BIOTECHNOLOGIES COR | $8M | 551,815 |
| 47 | UPSTREAM BIO INC | $7M | 786,783 |
| 48 | ERASCA INC | $7M | 406,702 |
| 49 | APOGEE THERAPEUTICS INC | $7M | 77,686 |
| 50 | COOPER COS INC | $6M | 89,883 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.